PD-L1 expression and tumour microenvironment immune type groups in meningioma

被引：0
|
作者：
Turner, C. [1 ,2 ]
Mclay, J. [3 ]
Correia, J. [2 ,4 ]
Highet, B. [5 ]
Curtis, M. [5 ]
Hermans, I. [6 ]
Dragunow, M. [2 ,7 ]
机构：
[1] Auckland City Hosp, Dept Anat Pathol, Auckland, New Zealand
[2] Univ Auckland, Neurosurg Res Unit, Ctr Brain Res, Auckland, New Zealand
[3] Univ Auckland, Dept Stat, Fac Sci, Auckland, New Zealand
[4] Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand
[5] Univ Auckland, Dept Anat & Med Imaging, Ctr Brain Res, Auckland, New Zealand
[6] Malaghan Inst Med Res, Wellington, New Zealand
[7] Univ Auckland, Dept Pharmacol, Ctr Brain Res, Auckland, New Zealand
来源：
HISTOPATHOLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
70
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [41] Differential expression of PD-L1 and IDO1 in association with the immune microenvironment in resected lung adenocarcinomas
    Zhang, M. Lisa
    Kem, Marina
    Mooradian, Meghan J.
    Eliane, Jean-Pierre
    Huynh, Tiffany G.
    Iafrate, A. John
    Gainor, Justin F.
    Mino-Kenudson, Mari
    MODERN PATHOLOGY, 2019, 32 (04) : 511 - 523
  • [42] Gastric carcinoma with lymphoid stroma: A study of Epstein-Barr virus, microsatellite instability, tumour immune microenvironment and PD-L1 expression
    Gullo, I.
    Goncalves, G.
    Pinto, M.
    Machado, F.
    Almeida, G. M.
    Oliveira, C.
    Carneiro, F.
    VIRCHOWS ARCHIV, 2016, 469 : S3 - S4
  • [43] The Immune Microenvironment of Microsatellite Stable Endometrial Carcinomas: Identification of Subsets with Higher PD-L1 Expression
    Crumley, Suzanne
    Tetzlaff, Michael T.
    Kurnit, Katherine
    Broaddus, Russell R.
    MODERN PATHOLOGY, 2017, 30 : 281A - 281A
  • [44] anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
    Shaochuan Liu
    Tingting Qin
    Zhujun Liu
    Jing Wang
    Yanan Jia
    Yingfang Feng
    Yuan Gao
    Kai Li
    Cell Death & Disease, 11
  • [45] PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer
    Gureviciene, Giedre
    Matulione, Jurgita
    Poskiene, Lina
    Miliauskas, Skaidrius
    Zemaitis, Marius
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [46] The Immune Microenvironment of Microsatellite Stable Endometrial Carcinomas: Identification of Subsets with Higher PD-L1 Expression
    Crumley, Suzanne
    Tetzlaff, Michael T.
    Kurnit, Katherine
    Broaddus, Russell R.
    LABORATORY INVESTIGATION, 2017, 97 : 281A - 281A
  • [47] Beyond PD-L1: unraveling the enigma of immunotherapy response in PD-L1 negative (<1%) NSCLC patients through quantification of PD-1/PD-L1 engagement in the tumour microenvironment
    Miles, J.
    Gumuzio, J.
    Calleja, V.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S99 - S100
  • [48] Implications of PD-L1 expression on the immune microenvironment in HER2-positive gastric cancer
    Chen, Yang
    Jia, Keren
    Chong, Xiaoyi
    Xie, Yi
    Jiang, Lei
    Peng, Haoxin
    Liu, Dan
    Yuan, Jiajia
    Li, Yanyan
    Feng, Xujiao
    Sun, Yu
    Li, Jian
    Zhang, Xiaotian
    Shen, Lin
    MOLECULAR CANCER, 2024, 23 (01)
  • [49] anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
    Liu, Shaochuan
    Qin, Tingting
    Liu, Zhujun
    Wang, Jing
    Jia, Yanan
    Fend, Yingfang
    Gao, Yuan
    Li, Kai
    CELL DEATH & DISEASE, 2020, 11 (05)
  • [50] Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma
    Patil, Pallavi A.
    Blakely, Andrew M.
    Lombardo, Kara A.
    Machan, Jason T.
    Miner, Thomas J.
    Wang, Li-Juan
    Marwaha, Alexander S.
    Matoso, Andres
    HISTOPATHOLOGY, 2018, 73 (01) : 124 - 136
12345